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Background
u Def: Malignant nerve sheath tumour arising from a 
peripheral nerve, from a pre-existing benign nerve 
sheath tumour (usually neurofibroma) or in a 
patient with neurofibromatosis type 1 (WHO, 2013)
u MPNST – rare, 5% of all STS
u Biologically aggressive, rapid progression and 
high mortality rate
u Malignant Triton tumour - MPNST with 
rhabdomyosarcomatous differentiation, very 
aggressive
u Poor prognostic factors – NF1 associated, truncal 
location, size > 5 cm, local recurrence, high grade
Author/ 
Centre





+ NR + NR NR +
Ducatman/ 
Mayo
1986 120 34% + + - NR - -
Wong/ Mayo 1998 134 52% - + - + + -
Carli/ Italy 2005 167 37% + + + - + +
Madhabana
nda/ India
2006 24 58% - NR NR NR + NR
Okada, 
Japan
2007 56 43% - + - - - -
Anghileri/ 
INT-MI
2007 205 NR - + + - + -
Longhi/ 
Rizzoli
2010 62 38% - + + + + -
Stucky/ 
Mayo
2012 175 60% + + + + - -
Significant prognostic factors
Objectives
u Identify the prognostic 
factors for local 
recurrence and distant 
metastasis
u Analyze the survival 
outcome
u Identify the prognostic 
factors related to 
patients’ survival 
Materials & Method
Restrospective study in Lerdsin Hospital 
from 2009-2017
32 patients (mean follow-
up 28 months)
Data collection from 
















































































































Marginal resection 4 13
Amputation 4 13
Median survival after surgery  
= 56 months
Margin status Positive 31%
Negative 66%
Unknown 3%






































Stage I 1 (3.7%) 0 0
Stage II 1 (3.7%) 0 0
Stage III 5 (18.5%) 7 (24.1%) 12 (41.4%)
Overall 7 (25.9%) 7 (24.1%) 12 (41.4%)
Variables N LR, n=7 (%) P-value N DM, n=12 
(%)
P-value
Age <45 9 2 (22) 0.571 10 6 (60) 0.140
≥45 18 5 (28) 19 6 (32)
Sex Male 10 2 (20) 0.475 12 8 (67) 0.026
Female 17 5 (29) 17 4 (24)
NF-1 status Positive 8 1 (13) 0.301 9 5 (56) 0.263
Negative 19 6 (32) 20 7 (35)
Size <5 cm 4 1 (25) 0.731 4 0 (0) 0.100
≥5 cm 23 6 (26) 25 12 (48)
Location Upper limb 4 1 (25) 0.273 4 1 (25) 0.732
Lower limb 14 2 (14) 15 7 (47)
Axial 9 4 (44) 10 4 (40)
Tumour grade Low 6 1 (33) 0.498 6 0 (0) 0.026
High 21 6 (29) 23 12 (52)
Margin status Negative 17 4 (24) 0.525 18 8 (44) 0.368
Positive 10 3 (30) 10 3 (30)
Radiotherapy Yes 13 5 (38) 0.118 14 7 (50) 0.231
No 11 1 (9) 11 3 (27)
Unknown 8 7
Chemotherapy Yes 4 1 (25) 0.731 4 2 (50) 0.477







































NF1 2.166 7.962 0.9-69.9 0.061
Grade (low vs 
high)








Longhi/ Rizzoli Stucky/ Mayo Lerdsin
Age Median, 39 Median, 44 Mean, 51
NF1 35% 32% 31%
Site – extremity | axial 77% | 23% 45% | 34% 69% | 31%
Size Median, 9cm 
(2-30)
Median, 6cm Mean, 12cm
(1-25)
Grade – high | Triton NR | 2% 61% | 3% 81% | 22%
Margin - positive 44% 11% 31%
Adjuvant Rx – RTX | CTX 48% | 29% 63% | 28% 56% |16%
Local recurrence 34% 22% 26%
Metastasis 40% 21% 41%





u High grade tumour, local recurrence and distant 
metastasis – poor prognostic factors for survival
u Tumour size, surgical margin and adjuvant 
therapy – no prognostic influence on the survival 
outcome
u Malignant triton tumour – highest cases 
compared to other studies and has lowest survival 
u Need larger multi-institutional study due to rarity of 
MPNST
